Generic Janumet is now available in the United States, marking a significant change for people managing type 2 diabetes with sitagliptin and metformin.
Janumet is a prescription diabetes medication originally marketed by Merck. It combines two active ingredients that work through different mechanisms to help lower blood glucose. For years, patients relied primarily on branded Janumet, but the arrival of FDA-approved generic versions in 2026 has created more options.
Patients searching for generic Janumet 50/500mg, Janumet 50/1000mg, Janumet XR, or lower-cost sitagliptin/metformin tablets often have several questions:
- Is generic Janumet as effective as the brand?
- Which companies manufacture the generic?
- How much can patients save in 2026?
- What is the difference between regular Janumet and Janumet XR?
- What side effects and kidney-related precautions matter?
This guide answers those questions using current prescribing information, FDA resources, and published diabetes research.
For background on other treatment classes, see the MyRxBox diabetes medication guide.
1. What Is Janumet (Sitagliptin and Metformin)?
Janumet is a fixed-dose combination medication used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes.
It contains two medicines:
Sitagliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that increases the activity of natural incretin hormones. These hormones help the pancreas release insulin in response to elevated blood glucose and reduce inappropriate glucagon secretion.
Metformin: A biguanide that primarily reduces glucose production in the liver and improves the body’s response to insulin.
Combining the two ingredients allows physicians to address more than one mechanism contributing to high blood sugar.
Janumet is not approved for treating type 1 diabetes or diabetic ketoacidosis.
Readers can review the individual ingredients through the MyRxBox sitagliptin medication information and metformin drug information.
How does the combination work?
People with type 2 diabetes may experience insulin resistance, increased glucose production by the liver, and insufficient insulin release in response to meals.
Metformin helps reduce liver glucose production, while sitagliptin works through the incretin system.
Together, they may provide greater glucose reduction than either medicine alone in selected patients.
According to the official Janumet prescribing information, treatment must be selected based on previous medication use, response, tolerability, and kidney function.
2. Is Generic Janumet Available in the United States in 2026?
Yes. FDA-approved generic sitagliptin and metformin tablets are available in U.S. pharmacies in 2026.
This is one of the most important recent developments for patients taking Janumet.
Generic versions contain the same two active ingredients as the branded medicine and are available in equivalent immediate-release strengths.
Which manufacturers make generic Janumet?
Several manufacturers have received approvals for sitagliptin/metformin products, including:
| Manufacturer | Formulation | U.S. status in 2026 |
|---|---|---|
| Merck | Janumet immediate-release | Original branded product |
| Merck | Janumet XR | Original branded extended-release product |
| Apotex | Generic sitagliptin/metformin | FDA-approved and launched |
| Sandoz | Generic sitagliptin/metformin | FDA-approved |
| Par Health | Generic extended-release combination | FDA-approved |
| Zydus | Zituvimet and Zituvimet XR | Separately approved branded combination products |
On June 3, 2026, Apotex publicly announced the U.S. launch of sitagliptin/metformin tablets and identified them as AB-rated to Janumet.
An AB therapeutic-equivalence rating supports substitution under applicable pharmacy laws and prescription requirements.
Source: Apotex — U.S. launch announcement, June 3, 2026.
Additional generic approvals may result in more manufacturers entering the market, although approval does not always mean immediate retail availability.
3. Is Generic Janumet the Same as Brand-Name Janumet?
FDA-approved generic medicines must meet regulatory standards for pharmaceutical quality, strength, dosage form, and bioequivalence.
A generic Janumet product approved as therapeutically equivalent contains the same active ingredients in the same strengths as its branded counterpart.
However, inactive ingredients, tablet appearance, manufacturer, and packaging may differ.
| Comparison | Brand Janumet | FDA-approved generic |
|---|---|---|
| Active ingredients | Sitagliptin + metformin | Sitagliptin + metformin |
| Purpose | Type 2 diabetes | Type 2 diabetes |
| Immediate-release strengths | 50/500mg and 50/1000mg | Matching approved strengths |
| Prescription required | Yes | Yes |
| Inactive ingredients | Brand-specific | May differ |
| Manufacturer | Merck | Multiple companies |
| Price | Often higher | May be lower |
| Clinical standards | FDA-approved | FDA-approved |
The FDA requires generic manufacturers to demonstrate that their products meet the standards applicable to approved generics.
Read the FDA’s explanation of generic drug requirements.
For more background, MyRxBox provides a brand versus generic medicine comparison.
Important: The same active ingredients do not mean that every international product can automatically be substituted for a U.S.-approved prescription. Regulatory approval and formulation must also match.
4. Generic Janumet Dosage: 50/500mg vs 50/1000mg
Janumet immediate-release tablets are available in two standard U.S. strengths.
| Tablet strength | Sitagliptin | Metformin |
|---|---|---|
| Janumet 50/500mg | 50mg | 500mg |
| Janumet 50/1000mg | 50mg | 1,000mg |
The first number identifies the sitagliptin amount. The second identifies the metformin amount.
Janumet 50/500mg
This tablet contains 50mg sitagliptin and 500mg metformin hydrochloride.
Under the U.S. prescribing label, the recommended initial regimen for an appropriate adult not previously taking metformin is one 50/500mg tablet twice daily with meals.
Metformin is usually increased gradually when clinically appropriate because gastrointestinal side effects may occur when treatment begins.
Janumet 50/1000mg
This tablet contains 50mg sitagliptin and 1,000mg metformin hydrochloride.
It may be prescribed when a higher metformin amount is appropriate, including for some patients already receiving metformin.
The labeled maximum daily amount is 100mg sitagliptin and 2,000mg metformin.
These are prescribing-label parameters, not instructions for patients to start or change doses independently.
Kidney function, current treatment, and gastrointestinal tolerability all influence the prescribed strength.
Official source: Janumet dosing and administration — DailyMed.
5. Janumet vs Janumet XR: What Is the Difference?
One of the most common sources of confusion is the difference between Janumet and Janumet XR.
Both contain sitagliptin and metformin, but their drug-release characteristics and administration schedules differ.
| Feature | Janumet | Janumet XR |
|---|---|---|
| Main ingredients | Sitagliptin + metformin | Sitagliptin + metformin |
| Metformin release | Immediate-release | Extended-release |
| Labeled frequency | Twice daily | Once daily |
| Food instructions | With meals | With a meal |
| Available U.S. strengths | 50/500, 50/1000mg | 50/500, 50/1000, 100/1000mg |
| Crush or split | Do not split or divide | Do not split, crush, or chew |
| Primary use | Type 2 diabetes | Type 2 diabetes |
Why choose an extended-release formulation?
Janumet XR releases the metformin component over a longer period. Its once-daily schedule may be more convenient for certain patients.
Some people tolerate extended-release metformin differently from immediate-release metformin, particularly regarding gastrointestinal symptoms.
However, XR is not automatically the better choice for everyone.
The FDA-approved label states that Janumet XR should be taken once daily with a meal and swallowed whole.
If two XR tablets are prescribed, they are taken together once daily according to the labeled instructions.
Patients changing formulations should have the total daily doses and kidney-related requirements reviewed by their prescriber.
Official reference: Janumet XR prescribing information.
6. Generic Janumet Price in 2026: Brand vs Generic
Generic availability may reduce medicine costs, particularly for patients paying without insurance.
However, Janumet does not have one fixed U.S. retail price.
The amount a patient pays depends on manufacturer, pharmacy, insurance coverage, deductible, quantity, and available discounts.
Example U.S. pharmacy acquisition-cost comparison
Published National Average Drug Acquisition Cost (NADAC) data provide a way to compare what pharmacies pay to obtain medicines.
For the 50mg/1000mg strength, publicly reported October 2026 figures included:
| Product | Approximate acquisition cost per tablet | Approximate cost for 60 tablets |
|---|---|---|
| Brand Janumet | $5.28 | $316.80 |
| Sandoz generic sitagliptin/metformin | $1.76 | $105.60 |
| Difference | $3.52 | $211.20 |
These figures compare the same strength using reported acquisition costs from different package listings. The 60-tablet totals normalize the per-tablet figures for comparison; they are not consumer quotes.
Sources: Sandoz generic NDC pricing and brand Janumet NDC pricing.
Pharmacy acquisition cost is not the same as the price patients pay. Actual out-of-pocket savings can be higher or lower.
Why do generic prices vary?
Pricing differences may result from:
- Manufacturer competition
- Distributor and wholesale arrangements
- Insurance formulary placement
- Pharmacy dispensing charges
- Package size
- Regional availability
- Prescription discount programs
For a more detailed purchasing comparison, see the MyRxBox prescription medicine price comparison guide.
Patients can also use the generic medicine savings calculator to compare hypothetical brand and generic costs.
7. Is It Cheaper to Take Sitagliptin and Metformin Separately?
Some patients receive sitagliptin and metformin as separate prescriptions rather than one fixed-dose combination.
For example, a clinician might prescribe sitagliptin as an individual tablet and metformin as another tablet.
Whether this costs less depends on pharmacy pricing and insurance coverage.
Potential advantages of separate tablets
Separate medicines allow the prescriber to adjust each ingredient individually.
This can be particularly important when kidney function changes because sitagliptin may require a lower dose.
Separate prescriptions may also offer additional flexibility when one medicine causes side effects.
Potential disadvantages
Taking two products may increase pill burden.
Separate prescriptions may also involve different copays or refill schedules.
Neither option is universally cheaper or medically preferable.
Patients considering a change should ask their pharmacist to compare the exact prescriptions and their total monthly costs.
The MyRxBox generic medicine equivalents directory provides background on identifying brand names and active ingredients.
8. How Effective Is Janumet for Lowering HbA1c?
HbA1c measures average blood glucose over approximately two to three months and is commonly used to assess diabetes treatment.
Clinical studies have shown that sitagliptin plus metformin can lower HbA1c more than either ingredient alone in certain treatment settings.
In a 24-week trial described in the Janumet label, the group receiving sitagliptin 50mg plus metformin 1,000mg twice daily had an average HbA1c reduction of approximately 1.9 percentage points from baseline.
The results depend on the starting HbA1c, previous treatment, and other patient characteristics.
They do not mean everyone taking Janumet will experience the same reduction.
What affects individual results?
Several factors influence treatment response, including:
- Baseline HbA1c
- Consistency with prescribed medication
- Diet and physical activity
- Kidney function
- Other diabetes medications
- Duration of diabetes
The treatment goal is not necessarily to reach the lowest possible HbA1c. Targets should reflect age, health conditions, hypoglycemia risk, and individual clinical circumstances.
The American Diabetes Association 2026 Standards of Care discuss medication selection and individualized treatment goals.
9. Common Janumet Side Effects
The most common issues associated with Janumet often involve the gastrointestinal system, particularly because it contains metformin.
Possible side effects include:
- Diarrhea
- Nausea
- Abdominal discomfort
- Gas or indigestion
- Headache
- Upper respiratory symptoms
Gastrointestinal effects may be more noticeable when metformin treatment first begins or when the prescribed amount increases.
Taking immediate-release Janumet with meals, as directed by its label, can help reduce stomach-related problems.
Does Janumet cause low blood sugar?
Sitagliptin and metformin generally have a lower risk of causing hypoglycemia when used without insulin or medications that directly stimulate insulin release.
However, the risk increases when Janumet is combined with insulin or sulfonylureas.
One example of a sulfonylurea is glipizide.
Readers comparing diabetes treatment classes can review glipizide 2.5mg (Glez) tablets and the broader diabetes medicine category.
Patients should never reduce or increase diabetes medication without appropriate medical advice.
10. Serious Janumet Warnings: Lactic Acidosis and Pancreatitis
Metformin-associated lactic acidosis
Janumet carries an FDA boxed warning for lactic acidosis, a rare but potentially life-threatening complication associated with metformin accumulation.
Risk factors include severe kidney impairment, significant liver disease, heavy alcohol consumption, certain medications, low-oxygen conditions, and some medical procedures.
Possible warning symptoms include unusual weakness, muscle pain, abdominal discomfort, severe drowsiness, and trouble breathing.
Suspected lactic acidosis requires emergency medical evaluation.
Pancreatitis
Acute pancreatitis has been reported in people taking sitagliptin.
Symptoms may include severe, persistent upper abdominal pain, sometimes radiating toward the back, with or without vomiting.
The prescribing information instructs that Janumet be stopped promptly if pancreatitis is suspected and that appropriate medical care be provided.
Other serious reactions
Additional warnings include:
- Severe allergic reactions
- Acute kidney injury
- Severe joint pain
- Bullous pemphigoid, a blistering skin disorder
- Vitamin B12 deficiency with long-term metformin use
These concerns are detailed in the FDA-approved Janumet label.
11. Can Patients With Kidney Disease Take Janumet?
Kidney function is a major consideration because both sitagliptin and metformin are affected by renal clearance.
The estimated glomerular filtration rate, or eGFR, is a standard measure used to assess kidney function.
Kidney function and Janumet immediate-release
| eGFR (mL/min/1.73m²) | U.S. label guidance |
|---|---|
| 45 or higher | May be used when otherwise appropriate, with monitoring |
| 30 to below 45 | Not recommended |
| Below 30 | Contraindicated |
The fixed combination may be unsuitable for patients needing a lower sitagliptin amount.
Janumet XR has related but not identical instructions for patients whose kidney function declines during treatment. Its label includes reassessment and sitagliptin dose limitations when eGFR falls below 45.
What about CT scans with contrast?
Certain imaging procedures using iodinated contrast may require a temporary interruption of metformin-containing therapy.
The need depends on kidney function, other risk factors, and the type of imaging procedure.
The label specifies particular circumstances in which Janumet should be withheld and kidney function reassessed before restarting.
Patients should tell the imaging department that they take Janumet and follow instructions from their medical team.
12. Does Janumet Cause Weight Loss or Weight Gain?
Janumet is not approved as a weight-loss medicine.
Metformin may have modest effects on body weight in some patients, while sitagliptin is generally considered weight-neutral.
Clinical trial results do not support presenting Janumet as a dedicated treatment for obesity.
Janumet vs Rybelsus for weight management
Rybelsus contains oral semaglutide, a GLP-1 receptor agonist. It acts differently from the sitagliptin component of Janumet.
GLP-1 receptor agonists may have greater effects on body weight than DPP-4 inhibitors, but individual products have different indications and dosing rules.
Importantly, the ADA’s 2026 guidance does not recommend routine combination of DPP-4 inhibitors with GLP-1 receptor agonists because there is generally no meaningful additional glucose-lowering benefit.
For more background, read Rybelsus 3mg vs 7mg vs 14mg.
A person considering Rybelsus while taking Janumet should ask the prescribing clinician to review whether the existing DPP-4 inhibitor remains appropriate.
13. Janumet vs Januvia: Are They the Same Medicine?
No.
Januvia contains sitagliptin alone.
Janumet contains sitagliptin plus metformin.
This distinction matters because both products contain sitagliptin.
Taking them together without a specific clinical reason could result in duplicate sitagliptin treatment.
| Feature | Januvia | Janumet |
|---|---|---|
| Sitagliptin | Yes | Yes |
| Metformin | No | Yes |
| Drug class | DPP-4 inhibitor | DPP-4 inhibitor + biguanide |
| Main use | Type 2 diabetes | Type 2 diabetes |
| Kidney-related dosing | Adjustment may be required | Fixed combination has additional restrictions |
Patients should check the generic ingredients on their prescriptions rather than relying only on brand names.
14. Janumet vs Other Type 2 Diabetes Medicines
The best treatment for type 2 diabetes depends on more than blood glucose alone.
Heart disease, kidney disease, body weight, hypoglycemia risk, and medication affordability are important considerations.
| Medicine or class | Main action | Important consideration |
|---|---|---|
| Janumet | DPP-4 inhibition + metformin | Oral combination; kidney-related limitations |
| Metformin | Reduces liver glucose production | Often used early in treatment |
| Glipizide | Stimulates insulin release | Higher hypoglycemia risk |
| Rybelsus | GLP-1 receptor agonist | Effects on glucose, appetite and body weight |
| SGLT2 inhibitors | Increase urinary glucose excretion | Certain drugs provide heart and kidney benefits |
| Insulin | Directly lowers blood glucose | Requires individualized dosing and monitoring |
Modern treatment guidelines often favor particular SGLT2 inhibitors or GLP-1-based therapies for patients who have specific cardiovascular or kidney-related conditions.
Janumet can remain an option for glucose control, but it does not offer the same established cardiovascular and kidney outcome benefits as certain medicines from those other classes.
MyRxBox has additional information in its diabetes treatment guide and Onglyza (saxagliptin) safety comparison.
15. What Should Patients Know Before Buying Generic Janumet Online?
Generic Janumet is a prescription medication. It should be obtained through a legally authorized pharmacy with a valid prescription.
Patients comparing online pharmacies should verify:
- Whether the pharmacy is licensed to serve their location.
- Whether a valid prescription is required.
- Whether the manufacturer and active ingredients are clearly identified.
- Whether the tablets are immediate-release or extended-release.
- Whether the strength matches the prescription.
- Whether the packaging includes appropriate labeling and expiration information.
- Whether a licensed pharmacist can answer medication-related questions.
Patients should be especially cautious with overseas products because an internationally marketed version may not have the same regulatory status as an FDA-approved product.
The FDA provides guidance through its BeSafeRx online pharmacy resource.
MyRxBox also has a guide to checking whether an online pharmacy is legitimate.
16. Frequently Asked Questions About Generic Janumet
Is there a generic for Janumet in 2026?
Yes. FDA-approved generic sitagliptin and metformin tablets are available in the United States. Apotex announced a U.S. launch in June 2026, and other manufacturers hold approvals for relevant formulations.
What is the generic name for Janumet?
The generic name is sitagliptin and metformin hydrochloride. These two active ingredients are combined in a fixed-dose tablet.
Is generic Janumet as effective as the brand?
FDA-approved generics rated therapeutically equivalent to Janumet must meet regulatory requirements supporting equivalent clinical use. Patients should confirm that the formulation and strength match their prescription.
What is the difference between Janumet 50/500mg and 50/1000mg?
Both contain 50mg of sitagliptin. The difference is the metformin amount: 500mg versus 1,000mg per tablet.
What is the maximum daily dose of Janumet?
The U.S. prescribing information specifies a maximum recommended daily amount of 100mg sitagliptin and 2,000mg metformin hydrochloride. This is a label limit, not an individual prescription recommendation.
Can Janumet be taken once daily?
Regular immediate-release Janumet is labeled for twice-daily use with meals. Janumet XR is an extended-release formulation labeled for once-daily administration with a meal.
Can Janumet XR tablets be split?
No. Janumet XR tablets should not be split, crushed, or chewed because this can interfere with their extended-release characteristics.
Does Janumet cause weight loss?
Janumet is not an approved weight-loss medicine. Some patients may experience modest weight changes, but its primary purpose is blood glucose control in adults with type 2 diabetes.
Can Janumet cause vitamin B12 deficiency?
Yes. Long-term metformin treatment can reduce vitamin B12 levels in some patients. The prescribing information recommends appropriate blood count and vitamin B12 monitoring.
Is Janumet safe for people with kidney problems?
Not for everyone. Immediate-release Janumet is contraindicated with eGFR below 30 and is not recommended with eGFR from 30 to below 45. Janumet XR has its own renal dosing and continuation instructions.
Can Janumet be used with insulin?
In some patients, yes, when prescribed by a clinician. The combination may increase hypoglycemia risk, and insulin dosing may need medical review.
Is generic Janumet cheaper than brand Janumet?
Generic products may cost less. Published October 2026 pharmacy acquisition-cost comparisons show a substantial difference for certain products, but the actual amount paid by a patient depends on pharmacy and insurance arrangements.
Can Janumet replace metformin?
Janumet contains metformin plus sitagliptin. It may be appropriate for selected patients needing combination treatment, but switching should be based on a clinician’s assessment.
Is Zituvimet the same as generic Janumet?
Zituvimet contains sitagliptin and metformin but was approved under its own new drug application. It should not automatically be treated as interchangeable with every Janumet prescription without checking the specific product and regulatory requirements.
17. Final Thoughts: Is Generic Janumet Worth Considering in 2026?
The introduction of generic sitagliptin and metformin products in the United States gives patients another option for managing the ongoing cost of type 2 diabetes treatment.
For patients already taking branded Janumet, a therapeutically equivalent FDA-approved generic may reduce expenses while maintaining the prescribed active ingredients and strength.
However, product selection should consider more than price.
The correct formulation, kidney function, other diabetes medicines, potential side effects, and individual glucose targets all matter.
Patients should consult their prescriber or pharmacist before changing between Janumet, Janumet XR, generic combination products, or separate sitagliptin and metformin tablets.
For more information about diabetes medicines and generic treatment comparisons, visit the MyRxBox diabetes medication guide, generic medicine equivalents directory, and generic savings calculator.
Medical References and Sources
- U.S. National Library of Medicine — DailyMed. Janumet (sitagliptin and metformin hydrochloride), prescribing information updated August 2026. Official Janumet label.
- U.S. National Library of Medicine — DailyMed. Janumet XR extended-release prescribing information, updated August 2026. Official Janumet XR label.
- Apotex Corp. U.S. launch of generic sitagliptin and metformin hydrochloride tablets, June 3, 2026. Manufacturer announcement.
- U.S. Food and Drug Administration. Generic Drug Facts. FDA generic medication standards.
- American Diabetes Association. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2026. ADA 2026 treatment guidance.
- Green JB et al. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine. 2015;373:232–242. Clinical trial.
- DailyMed — Apotex. Sitagliptin and Metformin Hydrochloride Tablets. Generic prescribing information.
- U.S. Food and Drug Administration. BeSafeRx: Your Source for Online Pharmacy Information. FDA pharmacy guidance.







